Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v2-FR
Language French French
Date Updated 2023-08-07 2023-02-01
Drug Identification Number 02412829 02412829
Brand name LEVEMIR FLEXTOUCH LEVEMIR FLEXTOUCH
Common or Proper name LEVEMIR FLEXTOUCH 5X3 ML LEVEMIR FLEXTOUCH 5X3 ML
Company Name NOVO NORDISK CANADA INC NOVO NORDISK CANADA INC
Ingredients INSULIN DETEMIR INSULIN DETEMIR
Strength(s) 100UNIT 100UNIT
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size EA EA
ATC code A10AE A10AE
ATC description INSULINS AND ANALOGUES INSULINS AND ANALOGUES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2023-07-31 2023-07-31
Actual discontinuation date 2023-08-04
Remaining supply date 2023-07-31 2023-07-01
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Patients who continue to have coverage for Levemir® FlexTouch® formats have the option to transition to the Penfill® format with NovoPen® 4, our durable insulin device that is available free-of-charge for patients at the pharmacy. Patients who continue to have coverage for Levemir® FlexTouch® formats have the option to transition to the Penfill® format with NovoPen® 4, our durable insulin device that is available free-of-charge for patients at the pharmacy.
Health Canada comments